Added to YB: 2026-06-24
Pitch date: 2026-06-22
ETON [bullish]
Eton Pharmaceuticals, Inc.
Author Info
Multibagger Ideas researches and shares thesis-driven ideas on potential multibaggers. Sign up for the newsletter.
Company Info
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Market Cap
$896.3M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
81.21
P/E
-599.12
EV/Sales
10.44
Sector
Pharmaceuticals
Category
growth
My Top 10 Multibagger Ideas for H2 2026 - Eton Pharmaceuticals, Inc.
ETON: Serial acquirer of orphan drugs for rare diseases; buys rights & commercializes therapies Big Pharma ignores. High gross margins, strong switching costs (stable peds patients don't switch), reliable reimbursement, operating leverage on flat sales infra. GAAP profitable, margins climbing, cash-funded M&A reseeds model; biggest products still ahead.
Read full article (1 min)